Home  About us  Contact us
     
Subscribe
To Subscribe to NBT
Home
News
Latest events
Suppliers
Media kit
Magazine issues
Submit editorial
Subscriptions
List rental
Via TV
Market Watch
 
 
High Potency Molecules in Development  |  Clinical Trials for Hyamax  |   New Appointments at LycoRed  |  Research Agreement for Bioponic Phytoceuticals
Research Agreement for Bioponic Phytoceuticals

Bioponic Phytoceuticals, Inc. announced recently that it has signed an agreement with Pediatric Neurosurgery and Childhood Hydrocephalus Center's principal Dr Jogi Pattisapu to research a treatment for childhood hydrocephalus using the company's curecumin product. Bioponic’s curecumin product is the first Bioresonant Phytotherapeutic formula of curcumin, the active ingredient found in turmeric root. Curcumin has been found to be an effective treatment for cystic fibrosis: "It can almost completely correct the measurable defects of the disease," said Michael Caplan of Yale University, “and various cancers.” B. Aggarwal of the University of Texas M.D. Anderson Cancer Center added: "We conclude that curcumin is a potent suppressor of cell viability and inducer of apoptosis in melanoma cell lines." Curcumin is considered to be a potent cancer chemopreventive agent and is recognized by Dr Pattisapu as a potential candidate for treating childhood hydrocephalus.

 Dr. Jogi Pattisapu is a practicing pediatric neurosurgeon and principal of Pediatric Neurosurgery and Childhood Hydrocephalus Center of Orlando, Florida. He is currently researching advanced treatments for childhood hydrocephalus to find alternatives to the shunt brain surgeries that are the currently accepted treatment for this ailment. "The opportunity to participate in potentially ground breaking research into the treatment of an ailment that effects more than 500,000 children will open up new possibilities for marketing the Company's innovative products into the medical biotech arena," said Steven M. Schorr, Chairman and CEO of Bioponic Phytoceuticals.

Bioponic Phytoceuticals is engaged in the formulation, production and distribution of Bioresonant Phytotherapeutic products for sale in the complementary alternative medicine and natural products markets. The company has developed a new patent pending healing modality "Bioresonant Phytotherapeutics" and has several branded product lines currently in national distribution — including the noted natural nasal spray: Flight Spray ( www.flightspray.com) — www.bioponic.com.

Copyright © 2008 Via Media Privacy Policy